Dr. John (Jack) Prior is Senior Director of BioProcess Engineering at Genzyme, a Sanofi Company. Dr. Prior joined Genzyme as a Process Engineer in 1997 after earning his Sc.D. in Chemical Engineering at the Massachusetts Institute of Technology. His work at Genzyme, a pioneer in biotechnology, has positively impacted the lives of thousands of individuals around the globe who suffer from rare genetic disorders. Through his efforts leading Manufacturing Science and Technology organizations for Genzyme, he has supported the commercialization and manufacture of biopharmaceuticals for rare but devastating genetic disorders such as Gaucher disease, Fabry disease, and Pompe disease as well as an injectable protein for the detection of thyroid cancer and a therapy to prevent organ transplant rejections. Dr. Prior has frequently led efforts to identify and correct the causes of critical manufacturing disruptions, enabling patients to continue receiving life-saving therapies. He currently leads a global bioprocess engineering group based in Framingham, MA that spearheads data management, data analysis, process characterization, and process modeling for biologics manufacturing operations in the U.S. and Europe. Dr. Prior has served on the Industrial Advisory Board for UConn’s Chemical Engineering program since 2006.